IMMP Q1 2026 Earnings Earnings Miss Estimates as Clinical Expenses Weigh on Results Teva Q1 2026 Earnings Strong EPS Beat on Cost Discipline Shares Edge Higher PPBT Q1 2025 Earnings Narrowing Losses and Pipeline Progress Drive Optimism RCUS Q1 2026 Earnings WiderthanExpected Loss Highlights Ongoing Biotech Development Costs SuRo Capital Corp SSSS Q1 2026 Earnings Massive EPS Surprise of 3727 as Reported Earnings Soar Above Negative Estimates BORR Q1 2026 Earnings Earnings Misses Estimates as Loss Widens